AI assistant
Lasa Supergenerics Limited — Call Transcript 2021
Jun 1, 2021
61953_rns_2021-06-01_55fe52f2-2cdf-461a-a0d3-99b8d66cff60.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [513 x 79] intentionally omitted <==
Ref. No.: LASA/SE/21-22/10
Tuesday, June 01, 2021
To, To, Corporate Services Department Corporate Services Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla Complex, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. BSE CODE –540702 NSE CODE: LASA
Sub: Dear Sir/Madam,
Sub. Intimation of earnings call on financial results for the quarter and financial year ended March 31, 2021.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Friday, June 04, 2021 at 02:00 p.m. IST for discussing the audited financial results of the Company for the quarter and financial year ended March 31, 2021.
The details of dial number are annexed herewith.
Please take the above on your records.
FOR LASA SUPERGENERICS LIMITED
NIDHI KULSHRESHTHA COMPANY SECRETARY AND COMPLIANCE OFFICER
ENCL: AS ABOVE.
==> picture [469 x 48] intentionally omitted <==
==> picture [513 x 79] intentionally omitted <==
==> picture [138 x 80] intentionally omitted <==
Lasa Supergenerics Limited Q4FY21 Earnings Conference Call Friday, June 04, 2021, at 02:00 p.m.
Tuesday, June 01, 2021 : Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended March 31[, ] 2021 (Q4FY21).
It will organize an earnings conference call on Friday, June 04[, ] 2021 @ 02:00 p.m. to discuss the Company’s Q4FY21 financial performance.
Dr. Omkar Herlekar - Chairperson & Managing Director will represent LASA Supergenerics Limited on the call.
The financial results are available on the corporate website - https://lasalabs.com.
DETAILS OF THE CONFERENCE CALL
| DETAILS OF THE CONFERENCE CALL | |
|---|---|
| Timing | 02:00 p.m. IST on Friday, June 04,2021 |
| Diamond Pass | _Click Here _ |
| Conference dial-in Primary number | 91 22 6280 1554 / 91 22 7115 8374 |
| Hong Kong Local Access Number | 800964448 / 852 30186877 |
| Singapore Local Access Number | 8001012045 / 65 31575746 |
| UK Local Access Number | 08081011573 / 44 2034785524 |
| USA Local Access Number | 18667462133/ 1 3233868721 |
==> picture [469 x 48] intentionally omitted <==
==> picture [513 x 79] intentionally omitted <==
About Lasa Supergenerics Limited (www.lasalabs.com/; BSE: 540702; NSE: LASA)
Incorporated in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. Our Company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers. The Company has its unit with state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 MT. The Company has over 25% of APIs exported to countries like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.
For more information contact: Mr. Hitesh Wadhwani Lasa Supergenerics Ltd. Tel: 7798888147 E-mail: [email protected]
==> picture [469 x 48] intentionally omitted <==